FindTrial
Sign In

Effect on recovery of patients with liver disease undergoing upper gastrointestinal endoscopy under propofol sedation

Comparison of patient recovery in between the child class A, B and C cirrhotic patients undergoing upper gastrointestinal endoscopy under propofol sedation â?? A prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020586
Enrollment
150
Registered
2019-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: NIL: NIL

Sponsors

Gaurav Sndwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Child class A,B and C Patients undergoing upper gastrointestinal endoscopy under propofol sedation

Exclusion criteria

Exclusion criteria: Pregnant patients Patients with a history of (H/O) Drug abuse Patients refusing consent History of Acute kidney injury Obese patients BMI > 30 H/o allergy to propofol Post liver transplant patients Tense ascites patients Patients undergoing upper gastrointestinal endoscopy under local anaesthesia

Design outcomes

Primary

MeasureTime frame
To compare the time of recovery in between the child class A,B and C cirrhotic patients who will be undergoing upper gastrointestinal endoscopy under propofol sedation. Timepoint: Until patient is discharged or shifted back to recovery—

Secondary

MeasureTime frame
To compare the total dose of propofol required for the procedure in between the child class A,B and C cirrhotic patients To compare the haemodynamic changes in between the child class A,B and C cirrhotic patients To compare the incidence and duration of post procedure hepatic encephalopathy among cirrhotic patients Timepoint: Until patient is discharged or shifted back to recovery—

Countries

India

Contacts

Public Contactgaurav sindwani

Institute of liver and biliary sciences

drsindwani25@gmail.com918728089898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026